NCT06809491View on ClinicalTrials.gov

One-year Recurrence-free Survival of Melanoma Patients Eligible for a Sentinel Lymph Node Biopsy

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 23, 2025

Primary Completion Date

January 23, 2025

Study Completion Date

January 31, 2025

Conditions
Melanoma, SkinAdjuvant Treatment
Trial Locations (1)

54500

CHRU Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT06809491 - One-year Recurrence-free Survival of Melanoma Patients Eligible for a Sentinel Lymph Node Biopsy | Biotech Hunter | Biotech Hunter